Free Trial

Unigestion Holding SA Acquires New Stake in The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Unigestion Holding SA acquired a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 2,351 shares of the company's stock, valued at approximately $382,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Brooklyn Investment Group raised its stake in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares during the last quarter. Continuum Advisory LLC lifted its stake in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after acquiring an additional 138 shares during the period. Millstone Evans Group LLC purchased a new stake in shares of Clorox in the 4th quarter valued at $31,000. Asset Planning Inc acquired a new stake in shares of Clorox in the fourth quarter worth $32,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in shares of Clorox during the fourth quarter worth $33,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CLX has been the subject of a number of recent research reports. Wells Fargo & Company reduced their price objective on Clorox from $161.00 to $155.00 and set an "equal weight" rating for the company in a research note on Wednesday, April 2nd. Barclays dropped their price objective on shares of Clorox from $139.00 to $134.00 and set an "underweight" rating on the stock in a research note on Friday. DA Davidson lowered their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Finally, Evercore ISI lifted their price target on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $156.75.

Get Our Latest Stock Report on CLX

Clorox Trading Up 0.3 %

Shares of NYSE CLX traded up $0.45 during trading on Friday, hitting $141.35. 1,249,590 shares of the company were exchanged, compared to its average volume of 1,295,815. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a fifty day moving average price of $147.39 and a 200-day moving average price of $157.24. The firm has a market capitalization of $17.41 billion, a PE ratio of 38.62, a P/E/G ratio of 2.62 and a beta of 0.61.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the business posted $2.16 earnings per share. As a group, equities research analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.45%. Clorox's dividend payout ratio (DPR) is currently 133.33%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines